Home> Products> affordable antiviral therapy steris

{ "products": [ { "_id": "668e6a917a3a9f14c496085b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "FLOCLOVIR 250 ", "description": "FLOCLOVIR 250 \nFamciclovir (250mg)\nIntroduction\nFLOCLOVIR 250 is an antiviral medication containing Famciclovir (250mg), primarily used to treat infections caused by herpes viruses, including herpes zoster (shingles), genital herpes, and cold sores. Famciclovir is a prodrug that is converted into penciclovir in the body, which then inhibits viral DNA replication, reducing the severity and duration of outbreaks.\n\nComposition\n\nFamciclovir (250mg): An antiviral agent that is effective against herpes simplex virus (HSV) types 1 and 2 and varicella-zoster virus (VZV).\nMechanism of Action\nFamciclovir is converted to penciclovir in the body. Penciclovir works by inhibiting the viral DNA polymerase enzyme, which is necessary for viral DNA synthesis and replication. By blocking this enzyme, penciclovir prevents the virus from multiplying, thereby controlling the infection and reducing symptoms.\n\nIndications\nFLOCLOVIR 250 is indicated for the treatment of:\n\nHerpes Zoster (Shingles): To reduce pain and accelerate healing of shingles rashes.\nGenital Herpes: For the treatment of initial and recurrent episodes of genital herpes, as well as for suppressive therapy to reduce the frequency of outbreaks.\nCold Sores (Herpes Labialis): To reduce the severity and duration of cold sores.\nDosage and Administration\n\nHerpes Zoster: The typical dosage is 500mg every 8 hours for 7 days.\nGenital Herpes (Initial Episode): 250mg three times daily for 5-10 days.\nGenital Herpes (Recurrent Episodes): 125mg twice daily for 5 days.\nSuppressive Therapy for Genital Herpes: 250mg twice daily.\nCold Sores: 1500mg as a single dose at the first sign of symptoms.\nDosage adjustments may be necessary for patients with renal impairment. It is crucial to start treatment at the first sign of an outbreak for maximum effectiveness.\nSide Effects\nCommon side effects may include:\n\nHeadache\nNausea\nDiarrhea\nFatigue\nAbdominal pain\nLess common but more severe side effects may include:\n\nAcute renal failure (particularly in patients with pre-existing kidney disease)\nAllergic reactions (rash, itching, swelling, severe dizziness, trouble breathing)\nPrecautions\n\nAllergy: Patients with a known allergy to Famciclovir, penciclovir, or any other components should avoid using this medication.\nRenal Impairment: Dosage adjustments are necessary for patients with kidney problems.\nPregnancy and Lactation: The safety of Famciclovir in pregnant or breastfeeding women has not been fully established. It should only be used if the potential benefits outweigh the risks.\nDrug Interactions\n\nProbenecid: May increase blood levels of Famciclovir, leading to increased risk of side effects.\nOther Antivirals: Combining with other antiviral drugs may enhance therapeutic effects but also increase the risk of side effects.\nConclusion\nFLOCLOVIR 250, with its active ingredient Famciclovir, provides an effective treatment option for managing herpes virus infections. By inhibiting viral replication, it helps reduce the severity and duration of outbreaks, offering relief to patients suffering from herpes zoster, genital herpes, and cold sores. As with any medication, it is essential to use FLOCLOVIR 250 as prescribed by a healthcare professional and to consult a doctor for any concerns or potential drug interactions. Proper use ensures optimal outcomes and minimizes the risk of side effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 312.0, "discountamount": 93.6, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "5 days", "7 days", "5-10 days", "Proper use", "first sign", "cold sores", "single dose", "Less common", "blood levels", "herpes zoster", "Abdominal pain", "typical dosage", "genital herpes", "herpes viruses", "shingles rashes", "Initial Episode", "Herpes Labialis", "antiviral agent", "kidney problems", "optimal outcomes", "Diarrhea Fatigue", "Other Antivirals", "other components", "renal impairment", "severe dizziness", "active ingredient", "viral replication", "Dosage adjustments", "Allergic reactions", "recurrent episodes", "potential benefits", "breastfeeding women", "suppressive therapy", "therapeutic effects", "severe side effects", "Common side effects", "Acute renal failure", "viral DNA synthesis", "antiviral medication", "herpes simplex virus", "maximum effectiveness", "other antiviral drugs", "viral DNA replication", "varicella-zoster virus", "healthcare professional", "herpes virus infections", "existing kidney disease", "effective treatment option", "potential drug interactions", "viral DNA polymerase enzyme" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1930, "imageuri": "https://productimages.withfloats.com/actual/668e6a94f07c99c3af8e5671.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e6a94f07c99c3af8e5671.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T11:03:45.437Z", "updatedon": "2024-07-10T11:03:45.437Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/floclovir-250-/1930", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "FLOCLOVIR 250 ", "category": "GENERAL RANGE", "tags": [ "Famciclovir 250mg dosage", "What is famciclovir 500 mg used for", "Famciclovir 250 mg price", "Famciclovir 500 mg dosage", "Is famciclovir an antibiotic", "Famciclovir side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68c29ba02244c906e7790e2b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TELAVINCE 300", "description": "TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function.\n\nTenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications.\n\n \nKey Indications:\n \n\nTELAVINCE 300 is indicated for:\n\nHIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg).\n\nChronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication.\n\n \nMechanism of Action:\n \nTenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread.\n\n \nDosage and Administration:\n \n\nRecommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food.\n\nFor HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen.\n\nFor Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment.\n\nDosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease.\n\n \nKey Benefits of TELAVINCE 300:\n \n\nPotent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication.\nOnce-Daily Dosing: Improves patient compliance and treatment adherence.\n\nBacked by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count).\n\nTrusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes.\n\nPart of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B.\n\n \nSafety and Precautions:\n \n\nRenal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment.\n\nBone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis.\n\nHepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment.\n\nLactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention.\n\n \n\nPossible Side Effects:\n \n\nMost patients tolerate TELAVINCE 300 well. However, some may experience:\n\nNausea\n\nDiarrhea\n\nHeadache\n\nFatigue\n\nRash\n\nDizziness\n\nDecreased bone mineral density\n\nRenal impairment (in rare cases)\n\nIf any side effects persist or worsen, consult a healthcare professional immediately.\n\n \nStorage Instructions:\n \n\nStore in a cool, dry place below 30°C.\n\nProtect from light and moisture.\n\nKeep out of reach of children.\n\n \n\nWhy Choose TELAVINCE 300?\n \n\nTELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards.\n\n \nDisclaimer:\n \n\nThis product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.", "price": 1480.0, "discountamount": 444.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2179, "imageuri": "https://productimages.withfloats.com/actual/68c29ba3794abb27ab248d73.png", "tileimageuri": "https://productimages.withfloats.com/tile/68c29ba3794abb27ab248d73.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-11T09:51:28.508Z", "updatedon": "2025-09-11T09:51:28.508Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/telavince-300/2179", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Tenofovir Disoproxil Fumarate Tablets ip 300 mg", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6863d70eaf0c9d1aa0c2d3e5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "FLUTICATONE VILO 200", "description": "FLUTICATONE VILO 200 is a combination inhalation therapy containing Fluticasone Furoate (200 mcg), a potent corticosteroid, and Vilanterol (25 mcg), a long-acting beta2-adrenergic agonist (LABA). This fixed-dose inhalation powder is specially formulated to manage and prevent symptoms associated with chronic obstructive pulmonary disease (COPD) and asthma, helping patients breathe more easily and maintain better lung function.\n\nThis combination works synergistically—Fluticasone Furoate reduces inflammation and swelling in the airways, while Vilanterol relaxes the airway muscles, offering long-lasting bronchodilation. The once-daily dosing improves compliance and ensures consistent therapeutic effects throughout the day.\n\nWhat is Fluticasone Furoate and Vilanterol Powder for Inhalation?\nFluticasone Furoate and Vilanterol Powder for Inhalation is a prescription combination medication used for long-term maintenance treatment of asthma and COPD. It is not a rescue medicine and should not be used to relieve sudden breathing problems.\n\nFluticasone Furoate 200 mcg: A highly effective corticosteroid that helps to reduce inflammation in the lungs.\n\nVilanterol 25 mcg: A bronchodilator that keeps airways open by relaxing muscles around them for up to 24 hours.\n\nUses of Fluticasone Furoate and Vilanterol Powder for Inhalation\nLong-term treatment of moderate to severe asthma in adults and adolescents.\n\nMaintenance treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema.\n\nReduces the frequency of asthma attacks and COPD exacerbations.\n\nImproves overall lung function, quality of life, and exercise capacity in chronic airway diseases.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation uses\n\nSide Effects of Fluticasone Furoate and Vilanterol Powder for Inhalation\nWhile FLUTICATONE VILO 200 is generally well-tolerated, it may cause some side effects in certain individuals, especially during the initial phase of therapy. Common and less frequent side effects may include:\n\nHeadache\n\nHoarseness or voice changes\n\nSore throat\n\nCough or throat irritation\n\nFungal infection in the mouth (oral thrush)\n\nIncreased heart rate or palpitations\n\nMuscle cramps\n\nDizziness\n\nRespiratory tract infections\n\nSerious but rare effects include allergic reactions, paradoxical bronchospasm, and increased risk of pneumonia in COPD patients.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation side effects\n\nPrecautions Before Using\nDo not use FLUTICATONE VILO 200 for acute asthma or COPD attacks. Always carry a fast-acting inhaler.\n\nInform your doctor if you have a history of heart disease, hypertension, thyroid problems, liver disorders, or tuberculosis.\n\nRinse your mouth after each use to avoid oral thrush.\n\nUse the inhaler as prescribed, and do not exceed the recommended dose.\n\nNot recommended for use in children under 12 years unless prescribed.\n\nInform your healthcare provider if you are pregnant, planning pregnancy, or breastfeeding.\n\nDrug Interactions\nCertain medications may affect the way FLUTICATONE VILO 200 works or increase the risk of side effects. Consult your doctor if you are taking:\n\nBeta-blockers (e.g., atenolol, propranolol)\n\nDiuretics (may increase the risk of hypokalemia)\n\nMAO inhibitors or tricyclic antidepressants (can enhance the effect of Vilanterol)\n\nAntifungal or antiviral medications (e.g., ketoconazole, ritonavir) that may increase corticosteroid levels\n\nOther long-acting beta agonists (LABAs) or inhaled corticosteroids\n\nWhat drugs interact with Fluticasone Furoate and Vilanterol?\nFluticasone Furoate and Vilanterol may interact with:\n\nStrong CYP3A4 inhibitors (like ritonavir, itraconazole) leading to increased steroid effects\n\nBeta-adrenergic blockers which may reduce the efficacy of vilanterol\n\nXanthine derivatives, diuretics, or digoxin, which may lead to heart rhythm disturbances when combined\n\nConclusion\nFLUTICATONE VILO 200 offers an effective, once-daily treatment for asthma and COPD by combining the anti-inflammatory power of Fluticasone Furoate 200 mcg and the long-acting bronchodilation of Vilanterol 25 mcg. It not only helps maintain clear airways but also improves your overall breathing comfort and quality of life. For optimal results, use the inhaler consistently and under your healthcare provider’s guidance.", "price": 740.0, "discountamount": 222.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "12 years", "24 hours", "increased risk", "drugs interact", "antiviral medications", "recommended dose", "airways open", "reduce inflammation", "acute asthma", "asthma attacks", "severe asthma", "copd attacks", "inhaler consistently", "optimal results", "breathing comfort", "longacting bronchodilation", "antiinflammatory power", "inhaled corticosteroids", "vilanterol antifungal", "tricyclic antidepressants", "taking betablockers", "prescribed inform", "tuberculosis rinse", "headache hoarseness", "initial phase", "generally welltolerated", "fluticatone vilo 200", "exercise capacity", "emphysema reduces", "chronic bronchitis", "relaxing muscles", "rescue medicine", "vilanterol relaxes", "prevent symptoms", "specially formulated", "vilanterol 25 mcg", "vilanterol powder", "rare effects", "ketoconazole ritonavir", "healthcare provider", "therapy common", "potent corticosteroid", "fluticasone furoate", "side effects", "lung function", "vilanterol fluticasone furoate", "copd exacerbations improves", "inhalation fluticasone furoate", "lung function quality", "fixeddose inhalation powder", "increase corticosteroid levels", "fastacting inhaler inform", "combination inhalation therapy", "side effects consult", "frequent side effects", "inhalation longterm treatment", "healthcare providers guidance", "ritonavir itraconazole leading", "highly effective corticosteroid", "effective oncedaily treatment", "heart rhythm disturbances", "strong cyp3a4 inhibitors", "hypokalemia mao inhibitors", "atenolol propranolol diuretics", "breastfeeding drug interactions", "pregnant planning pregnancy", "avoid oral thrush", "sore throat cough", "adolescents maintenance treatment", "longterm maintenance treatment", "prescription combination medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2140, "imageuri": "https://productimages.withfloats.com/actual/686785bc0500f068046215ba.png", "tileimageuri": "https://productimages.withfloats.com/tile/686785bc0500f068046215ba.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-01T12:39:42.59Z", "updatedon": "2025-07-04T07:41:47.804Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/fluticatone-vilo-200/2140", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "fluticasone furoate and vilanterol powder for inhalation", "category": "ASTHMARANGE", "tags": [ "fluticasone furoate and vilanterol powder for inhalation" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66d6df52731125bdd4e1003b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALGANCICLOVIR TABLET IP 450 MG", "description": "VOLANE SOURCE 450\nVALGANCICLOVIR TABLET IP 450 MG\nVOLANE SOURCE 450 contains Valganciclovir Tablet IP 450 mg, an antiviral medication used to treat infections caused by cytomegalovirus (CMV). CMV can affect various organs and is particularly dangerous in people with weakened immune systems, such as those who have undergone organ transplants or are living with HIV. Valganciclovir is essential for preventing CMV infections and managing existing ones.\n\n \nKey Benefits:\n \n\nPrevention of CMV Infections: VOLANE SOURCE 450 is primarily used to prevent CMV infections in high-risk individuals, especially those who have undergone organ transplants.\nTreatment of CMV Retinitis: It is also effective in treating CMV retinitis, a severe eye infection that can lead to blindness in people with weakened immune systems.\nHigh Oral Bioavailability: Valganciclovir offers a convenient oral option with high bioavailability, making it easier for patients to manage their treatment at home.\n \n\nHow Does It Work?\n\nValganciclovir, the active ingredient in VOLANE SOURCE 450, is converted into ganciclovir in the body. Ganciclovir works by inhibiting the replication of viral DNA. It incorporates into the viral DNA, leading to chain termination and preventing the virus from multiplying. This action helps control the spread of the CMV infection within the body, reducing symptoms and preventing further complications.\n\n \n\nDirections for Use:\n \n\nDosage: The dosage of VOLANE SOURCE 450 is determined by the healthcare provider based on the patient's medical condition, weight, and response to treatment.\nAdministration: The tablet should be taken orally with food to enhance absorption. Swallow the tablet whole without crushing or chewing.\nDuration: Follow the prescribed course of treatment, even if symptoms improve, to ensure the complete eradication of the virus.\n \n\nSide Effects:\n \n\nCommon Side Effects: Nausea, diarrhea, headache, and fatigue are some of the common side effects associated with Valganciclovir.\nSerious Side Effects: In rare cases, VOLANE SOURCE 450 may cause severe side effects such as bone marrow suppression, which can lead to conditions like anemia, leukopenia, and thrombocytopenia. Immediate medical attention is required if any signs of these conditions occur.\nMonitoring: Regular blood tests are recommended to monitor blood cell counts and kidney function during treatment with VOLANE SOURCE 450.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 4207.0, "discountamount": 1263.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "viral DNA", "rare cases", "Key Benefits", "CMV Retinitis", "VOLANE SOURCE", "CMV infection", "various organs", "kidney function", "prescribed course", "chain termination", "active ingredient", "organ transplants", "medical condition", "blood cell counts", "healthcare provider", "severe side effects", "Common Side Effects", "Regular blood tests", "complete eradication", "antiviral medication", "high bioavailability", "severe eye infection", "Serious Side Effects", "high-risk individuals", "convenient oral option", "bone marrow suppression", "weakened immune systems", "VALGANCICLOVIR TABLET IP", "High Oral Bioavailability", "Immediate medical attention" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1950, "imageuri": "https://productimages.withfloats.com/actual/66d6df583e7c26d6528cd0c0.png", "tileimageuri": "https://productimages.withfloats.com/tile/66d6df583e7c26d6528cd0c0.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-03T10:05:06.943Z", "updatedon": "2024-09-03T10:05:06.943Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/valganciclovir-tablet-ip-450-mg/1950", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VOLANE SOURCE 450", "category": "CARDIOLOGYRANGE", "tags": [ "VALGANCICLOVIR TABLET IP 450 MG USUE" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66d6c6e49c64df098caefc78", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Atorvastatin (10 mg), Ezetimibe IP(10mg)", "description": "ATOVASTRIN EZ 10/10\nAtorvastatin (10 mg), Ezetimibe IP(10mg)\nATOVASTRIN EZ 10/10 is a potent cholesterol-lowering medication that combines two active ingredients, Atorvastatin (10 mg) and Ezetimibe IP (10 mg), to effectively manage and reduce elevated cholesterol levels. This combination therapy is designed for individuals who require more than just dietary changes and exercise to control their cholesterol levels. ATOVASTRIN EZ 10/10 is particularly beneficial for patients at high risk of cardiovascular diseases, such as heart attacks and strokes, providing a dual mechanism to lower bad cholesterol (LDL) and total cholesterol in the blood.\n\n \n\nKey Benefits:\n \n\nEffective Cholesterol Reduction: ATOVASTRIN EZ 10/10 significantly lowers LDL cholesterol, total cholesterol, and triglycerides while increasing HDL (good cholesterol) levels, promoting better cardiovascular health.\n\nDual Mechanism: The combination of Atorvastatin and Ezetimibe offers a comprehensive approach to managing cholesterol levels by both reducing the production of cholesterol in the liver and decreasing its absorption from the diet.\n\nCardiovascular Protection: By effectively lowering cholesterol levels, ATOVASTRIN EZ 10/10 helps reduce the risk of heart attacks, strokes, and other cardiovascular events, especially in individuals with a history of heart disease or high cholesterol.\n\nConvenient Dosage: The combination of two effective ingredients in a single tablet simplifies treatment regimens, improving patient compliance and outcomes.\n\nSupports Overall Health: Lowering cholesterol levels contributes to better overall health by reducing the strain on the heart and blood vessels, thereby lowering the risk of developing more severe health issues.\n\n \n\nHow Does It Work?\n \n\nATOVASTRIN EZ 10/10 works through a dual-action mechanism:\n\nAtorvastatin: By inhibiting the enzyme HMG-CoA reductase in the liver, Atorvastatin reduces the liver's production of cholesterol. This decrease in cholesterol production leads to a lower level of LDL cholesterol in the blood.\n\nEzetimibe: This ingredient targets the absorption of cholesterol in the small intestine. By blocking the absorption of dietary cholesterol, Ezetimibe reduces the amount of cholesterol that enters the bloodstream, further lowering LDL cholesterol levels.\n\nThis dual action makes ATOVASTRIN EZ 10/10 a powerful option for individuals who need to lower their cholesterol levels more effectively than with a statin alone.\n\n \n\nDirections for Use:\n \n\nDosage: Take one tablet of ATOVASTRIN EZ 10/10 daily, or as prescribed by your healthcare provider. It is typically taken once a day with or without food.\n\nConsistency: For best results, take the medication at the same time each day. This helps maintain a consistent level of the medication in your bloodstream.\n\nFollow the Prescription: Do not alter the dosage or frequency without consulting your healthcare provider. Continue taking the medication even if you feel well, as stopping suddenly can lead to a spike in cholesterol levels.\n\nLifestyle Changes: While taking ATOVASTRIN EZ 10/10, maintain a healthy diet, exercise regularly, and avoid smoking to maximize the medication’s benefits.\n\n \n\nSide Effects:\n \n\nWhile ATOVASTRIN EZ 10/10 is generally well-tolerated, some individuals may experience side effects. Common side effects include:\n\nMuscle Pain or Weakness: Some patients may experience muscle pain, tenderness, or weakness. If this occurs, consult your healthcare provider, as it could indicate a rare but serious condition called rhabdomyolysis.\n\nDigestive Issues: Nausea, diarrhea, or constipation may occur as your body adjusts to the medication.\n\nLiver Function: In rare cases, the medication may affect liver function, leading to symptoms like yellowing of the skin or eyes (jaundice). Regular monitoring of liver enzymes may be required.\n\nAllergic Reactions: Although rare, some individuals may experience allergic reactions, such as rash, itching, or swelling. Seek immediate medical attention if you experience difficulty breathing or severe swelling.\n\nHeadache: Some users might experience headaches, which usually diminish as the body adapts to the medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 155.0, "discountamount": 46.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "high risk", "same time", "rare cases", "one tablet", "Muscle Pain", "dual action", "lower level", "healthy diet", "Key Benefits", "Ezetimibe IP", "best results", "blood vessels", "liver enzymes", "heart disease", "heart attacks", "single tablet", "ATOVASTRIN EZ", "Liver Function", "dual mechanism", "Overall Health", "severe swelling", "powerful option", "small intestine", "bad cholesterol", "dietary changes", "consistent level", "high cholesterol", "Digestive Issues", "Convenient Dosage", "serious condition", "Lifestyle Changes", "HMG-CoA reductase", "total cholesterol", "Allergic Reactions", "Regular monitoring", "patient compliance", "treatment regimens", "combination therapy", "healthcare provider", "dietary cholesterol", "Common side effects", "difficulty breathing", "severe health issues", "dual-action mechanism", "cardiovascular health", "cholesterol production", "comprehensive approach", "LDL cholesterol levels", "two active ingredients", "cardiovascular diseases", "good cholesterol) levels", "Cardiovascular Protection", "two effective ingredients", "elevated cholesterol levels", "other cardiovascular events", "immediate medical attention", "Effective Cholesterol Reduction", "potent cholesterol-lowering medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1947, "imageuri": "https://productimages.withfloats.com/actual/66d6c6e8e3614a76bf43299b.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/66d6c6e8e3614a76bf43299b.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-03T08:20:52.281Z", "updatedon": "2024-09-03T08:20:52.281Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/atorvastatin-10-mg-ezetimibe-ip-10mg-/1947", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ATOVASTRIN EZ 10/10 ", "category": "CARDIOLOGYRANGE", "tags": [ "atorvastatin 10 mg uses in hindi", "atorvastatin 10 mg uses", "atorvastatin (10 mg) ezetimibe ip(10mg) uses in hi", "ezetimibe ip(10mg) uses in hindi", "ezetimibe ip(10mg) uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e8611b9f7300708fe1240", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIOGLIMITERIS 1/0.2 ", "description": "TRIOGLIMITERIS 1/0.2 \nVoglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg\nIntroduction\n\nTRIOGLIMITERIS 1/0.2 is a combination medication containing Voglibose, Glimepiride, and Metformin Hydrochloride. It is primarily used in the management of type 2 diabetes mellitus to improve glycemic control through different mechanisms of action targeting glucose metabolism.\n\nComposition\n\nVoglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the digestion of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels.\nGlimepiride (1 mg): A sulfonylurea derivative that stimulates insulin release from pancreatic beta cells, enhancing glucose uptake in peripheral tissues.\nMetformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, improves insulin sensitivity in peripheral tissues, and reduces intestinal glucose absorption.\nMechanism of Action\n\nTRIOGLIMITERIS 1/0.2 combines the actions of its components to achieve optimal glycemic control:\n\nVoglibose: Inhibits alpha-glucosidase enzymes in the intestine, delaying carbohydrate digestion and reducing the absorption of glucose after meals.\nGlimepiride: Stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, thereby lowering blood glucose levels.\nMetformin Hydrochloride: Decreases hepatic glucose production through suppression of gluconeogenesis and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.\nIndications\n\nTRIOGLIMITERIS 1/0.2 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults when diet, exercise, and monotherapy with metformin or sulfonylureas alone are not sufficient.\nDosage and Administration\n\nThe typical dosage of TRIOGLIMITERIS 1/0.2 is one tablet taken orally with meals, usually once or twice daily.\nDosage adjustments may be required based on individual patient response, blood glucose levels, and renal function.\nIt is essential to adhere to the prescribed dosage regimen to achieve optimal therapeutic outcomes.\nSide Effects\n\nCommon side effects of TRIOGLIMITERIS 1/0.2 may include:\n\nHypoglycemia (especially when used in combination with insulin or other antidiabetic medications)\nGastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort)\nWeight gain (mainly associated with sulfonylureas)\nMore severe side effects can include:\n\nAllergic reactions (rash, itching, swelling)\nLactic acidosis (rare but serious adverse effect associated with metformin use)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with renal impairment, hepatic dysfunction, or other significant medical conditions that may affect drug metabolism or excretion.\nRegular monitoring of blood glucose levels, renal function, and liver function is recommended during treatment with TRIOGLIMITERIS 1/0.2.\nAvoid use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.\nDrug Interactions\n\nTRIOGLIMITERIS 1/0.2 may interact with other medications affecting blood glucose levels, such as insulin, other oral antidiabetic agents, or drugs that affect renal function or hepatic metabolism. Close monitoring and dose adjustments may be necessary.\nConclusion\n\nTRIOGLIMITERIS 1/0.2 provides a comprehensive approach to managing type 2 diabetes mellitus by combining Voglibose, Glimepiride, and Metformin Hydrochloride. This combination targets different aspects of glucose metabolism, enhancing insulin secretion, reducing hepatic glucose production, and delaying carbohydrate absorption in the intestine. Proper dosage, administration, and monitoring for side effects are essential to achieve and maintain optimal glycemic control in diabetic patients using TRIOGLIMITERIS 1/0.2. Consultation with a healthcare provider is recommended for personalized treatment plans and management of diabetes with this medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "500 mg", "0.2 mg", "one tablet", "Weight gain", "Glimepiride 1", "metformin use", "Proper dosage", "Glimepiride (1", "dosage regimen", "typical dosage", "renal function", "insulin release", "drug metabolism", "Lactic acidosis", "Close monitoring", "dose adjustments", "renal impairment", "diabetic patients", "insulin secretion", "different aspects", "Drug Interactions", "other medications", "Regular monitoring", "Dosage adjustments", "Allergic reactions", "peripheral tissues", "hepatic metabolism", "glucose metabolism", "insulin sensitivity", "healthcare provider", "Hepatic dysfunction", "Common side effects", "abdominal discomfort", "different mechanisms", "liver function tests", "diabetic ketoacidosis", "pancreatic beta cells", "combination medication", "carbohydrate digestion", "comprehensive approach", "serious adverse effect", "Metformin Hydrochloride", "carbohydrate absorption", "sulfonylurea derivative", "glucose-dependent manner", "optimal glycemic control", "type 1 diabetes mellitus", "type 2 diabetes mellitus", "More severe side effects", "alpha-glucosidase enzymes", "peripheral glucose uptake", "hepatic glucose production", "alpha-glucosidase inhibitor", "individual patient response", "personalized treatment plans", "optimal therapeutic outcomes", "Gastrointestinal disturbances", "intestinal glucose absorption", "other antidiabetic medications", "other oral antidiabetic agents", "postprandial blood glucose levels", "other significant medical conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1939, "imageuri": "https://productimages.withfloats.com/actual/668e86143a68154e11e7d822.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e86143a68154e11e7d822.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T13:01:05.875Z", "updatedon": "2024-07-10T13:01:05.875Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trioglimiteris-1-0-2-/1939", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIOGLIMITERIS 1/0.2 ", "category": "DIABETIC RANGE", "tags": [ "glimepiride 1mg+metformin 500mg+voglibose 0.2 mg", "Glimepiride 2mg Metformin 500mg Voglibose 0.2 mg b", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg", "voglibose glimepiride & metformin hydrochloride (s", "voglibose glimepiride + metformin hydrochloride us", "glimepiride 1mg+metformin 500mg+voglibose 0.3 mg", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg g", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e7ff07e47881008f6860e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIMETAZ CR 80 ", "description": "TRIMETAZ CR 80 \nTrimetazidine (80mg)\nIntroduction\nTRIMETAZ CR 80 is a medication containing Trimetazidine hydrochloride, formulated to treat angina pectoris and certain other cardiovascular conditions. It is known for its metabolic effects on the heart muscle, improving myocardial efficiency and reducing symptoms associated with ischemic heart disease.\n\nComposition\n\nTrimetazidine (80mg): The active ingredient, Trimetazidine, acts as a cellular metabolic agent that enhances myocardial glucose utilization and improves energy production in the heart muscle.\nMechanism of Action\nTrimetazidine exerts its therapeutic effects through several mechanisms:\n\nMetabolic Regulation: Shifts myocardial energy substrate utilization from fatty acids toward glucose oxidation, which is more efficient and requires less oxygen.\nAnti-ischemic Effect: Protects the heart against ischemic damage by preserving cellular energy metabolism and reducing oxidative stress.\nImprovement in Symptomatology: Reduces angina symptoms such as chest pain, shortness of breath, and exercise intolerance by enhancing myocardial function.\nIndications\nTRIMETAZ CR 80 is indicated for:\n\nChronic Stable Angina Pectoris: Used as adjunctive therapy in patients who are inadequately controlled with other anti-anginal medications.\nIschemic Heart Disease: Helps improve myocardial function and reduce symptoms associated with coronary artery disease.\nDosage and Administration\n\nThe usual dosage of TRIMETAZ CR 80 is one tablet (80mg) taken orally twice daily, preferably with meals.\nThe extended-release formulation ensures sustained therapeutic levels of Trimetazidine throughout the day.\nDosage adjustments may be necessary based on individual patient response and tolerance.\nSide Effects\nCommon side effects may include:\n\nHeadache\nDizziness\nNausea\nGastrointestinal disturbances (such as abdominal pain or diarrhea)\nSevere side effects are rare but may include:\n\nAllergic reactions (rash, itching, swelling)\nExtrapyramidal symptoms (involuntary movements)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with severe renal impairment or hepatic dysfunction, as Trimetazidine metabolism may be altered.\nMonitor patients for signs of extrapyramidal symptoms, especially in patients with Parkinson's disease or other movement disorders.\nAvoid abrupt discontinuation of Trimetazidine, as it may worsen angina symptoms.\nDrug Interactions\n\nTrimetazidine may interact with other medications that affect myocardial metabolism or cardiac function, including beta-blockers and calcium channel blockers. Close monitoring is recommended when used concomitantly.\nConclusion\nTRIMETAZ CR 80 is a valuable therapeutic option for managing chronic stable angina pectoris and ischemic heart disease by improving myocardial efficiency and reducing symptoms associated with cardiac ischemia. Its mechanism of action, focusing on metabolic modulation and anti-ischemic effects, makes it an effective adjunctive therapy in patients with inadequate symptom control on standard anti-anginal medications. Proper dosage, administration, and monitoring for side effects are essential to ensure safe and effective use of TRIMETAZ CR 80 in cardiovascular patients. Consultation with a healthcare provider is recommended for personalized treatment plans and management of cardiac conditions with TRIMETAZ CR 80.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 435.0, "discountamount": 130.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "one tablet", "chest pain", "less oxygen", "fatty acids", "TRIMETAZ CR", "usual dosage", "heart muscle", "Proper dosage", "effective use", "abdominal pain", "angina symptoms", "ischemic damage", "Close monitoring", "cardiac ischemia", "oxidative stress", "cardiac function", "Drug Interactions", "active ingredient", "glucose oxidation", "metabolic effects", "energy production", "other medications", "Dosage adjustments", "Allergic reactions", "adjunctive therapy", "several mechanisms", "cardiac conditions", "healthcare provider", "Hepatic dysfunction", "myocardial function", "therapeutic effects", "Severe side effects", "Common side effects", "metabolic modulation", "Metabolic Regulation", "liver function tests", "involuntary movements", "anti-ischemic effects", "myocardial efficiency", "myocardial metabolism", "abrupt discontinuation", "ischemic heart disease", "Extrapyramidal symptoms", "cardiovascular patients", "coronary artery disease", "severe renal impairment", "Trimetazidine metabolism", "cellular metabolic agent", "other movement disorders", "calcium channel blockers", "cellular energy metabolism", "inadequate symptom control", "Trimetazidine hydrochloride", "valuable therapeutic option", "individual patient response", "extended-release formulation", "sustained therapeutic levels", "personalized treatment plans", "Gastrointestinal disturbances", "other anti-anginal medications", "myocardial glucose utilization", "Chronic Stable Angina Pectoris", "other cardiovascular conditions", "standard anti-anginal medications", "myocardial energy substrate utilization" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1938, "imageuri": "https://productimages.withfloats.com/actual/668e7ff3f07c99c3af8e8504.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e7ff3f07c99c3af8e8504.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T12:34:56.538Z", "updatedon": "2024-07-10T12:34:56.538Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trimetaz-cr-80-/1938", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIMETAZ CR 80 ", "category": "CARDIOLOGYRANGE", "tags": [ "Trimetazidine 80mg price", "Trimetazidine 35 mg uses", "Trimetazidine 80 mg brand name", "When to stop taking trimetazidine", "Trimetazidine hydrochloride extended release CAPSU", "Trimetazidine mechanism of action", "Trimetazidine 35 mg brand name", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e7de4a6e2f4114c6f8d28", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LAXAVATAR LB DS ", "description": "LAXAVATAR LB DS \nLactic Acid Bacillus 120 Million\nIntroduction\nLAXAVATAR LB DS is a probiotic supplement containing Lactic Acid Bacillus, designed to promote gastrointestinal health and support the balance of intestinal flora. It helps in maintaining digestive balance and potentially offers benefits in managing various gastrointestinal conditions.\n\nComposition\n\nLactic Acid Bacillus: Each dose of LAXAVATAR LB DS provides 120 million colony-forming units (CFUs) of Lactic Acid Bacillus. This probiotic strain is known for its ability to restore and maintain the natural balance of bacteria in the gut.\nMechanism of Action\nLactic Acid Bacillus works through several mechanisms to support gastrointestinal health:\n\nRestoration of Gut Flora: Helps restore the natural balance of beneficial bacteria in the gut, which may be disrupted due to factors like antibiotic use or dietary changes.\nSupports Digestive Function: Enhances digestion and nutrient absorption by promoting a healthy gut environment.\nImmune Modulation: Modulates the immune response within the gut, supporting overall immune function and health.\nIndications\nLAXAVATAR LB DS is indicated for:\n\nDigestive Health: Supports digestive function and helps maintain gastrointestinal balance.\nAntibiotic-Associated Diarrhea: Helps prevent and manage diarrhea associated with antibiotic use by replenishing beneficial gut bacteria.\nIrritable Bowel Syndrome (IBS): May provide symptomatic relief in individuals with IBS by promoting gut health.\nGeneral Well-being: Contributes to overall well-being by supporting a healthy digestive system.\nDosage and Administration\n\nThe typical dosage for adults and children over 12 years old is one capsule daily, preferably taken with a meal.\nCapsules should be swallowed whole with water and not chewed or crushed.\nIt is recommended to use LAXAVATAR LB DS regularly for best results, especially during periods of antibiotic therapy or digestive disturbances.\nSide Effects\nLAXAVATAR LB DS is generally well-tolerated. Common side effects, if any, may include mild gastrointestinal symptoms such as:\n\nBloating\nFlatulence\nMild abdominal discomfort\nSevere side effects are rare but may include allergic reactions in sensitive individuals. Discontinue use and consult a healthcare professional if adverse reactions occur.\n\nPrecautions\n\nUse with caution in individuals with compromised immune systems or severe underlying health conditions, as probiotics may interact with medications or exacerbate existing conditions.\nConsult a healthcare professional before starting LAXAVATAR LB DS, especially if pregnant, nursing, or undergoing medical treatment.\nConclusion\nLAXAVATAR LB DS provides a convenient and effective way to support digestive health with its formulation of Lactic Acid Bacillus. By replenishing beneficial gut bacteria, it helps maintain gastrointestinal balance, supports digestion, and contributes to overall well-being. Regular use of LAXAVATAR LB DS can be beneficial in managing digestive disturbances, promoting gut health, and enhancing immune function. As with any dietary supplement, it is advisable to seek guidance from a healthcare provider to determine the most appropriate use based on individual health needs.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 85.0, "discountamount": 25.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Gut Flora", "gut health", "Regular use", "one capsule", "best results", "effective way", "typical dosage", "antibiotic use", "immune systems", "appropriate use", "natural balance", "dietary changes", "immune response", "LAXAVATAR LB DS", "probiotic strain", "intestinal flora", "Digestive Health", "digestive balance", "medical treatment", "adverse reactions", "Immune Modulation", "dietary supplement", "allergic reactions", "antibiotic therapy", "General Well-being", "symptomatic relief", "several mechanisms", "overall well-being", "Digestive Function", "healthcare provider", "nutrient absorption", "beneficial bacteria", "existing conditions", "Common side effects", "Severe side effects", "probiotic supplement", "Lactic Acid Bacillus", "sensitive individuals", "digestive disturbances", "healthcare professional", "gastrointestinal health", "overall immune function", "beneficial gut bacteria", "healthy gut environment", "individual health needs", "gastrointestinal balance", "healthy digestive system", "Irritable Bowel Syndrome", "Mild abdominal discomfort", "Antibiotic-Associated Diarrhea", "mild gastrointestinal symptoms", "120 million colony-forming units", "various gastrointestinal conditions", "severe underlying health conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1937, "imageuri": "https://productimages.withfloats.com/actual/668e7de7d81299e9814a2653.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e7de7d81299e9814a2653.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T12:26:12.188Z", "updatedon": "2024-07-10T12:26:12.188Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/laxavatar-lb-ds-/1937", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LAXAVATAR LB DS ", "category": "GENERAL RANGE", "tags": [ "Lactic Acid Bacillus how to use", "", "Lactic Acid Bacillus Capsules", "Lactic acid Bacillus benefits", "Lactic acid bacillus 60 Million Spores uses", "Lactic acid Bacillus uses for babies", "", "Lactic acid bacillus powder", "Lactic Acid Bacillus Tablet 60 Million Spores", "Lactic acid Bacillus dosage for child" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e77e853fc1c2298508399", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD PIO 20/15 ", "description": "TENELIGOLD PIO 20/15 \nTeneligliptin & Pioglitazone\nIntroduction\nTENELIGOLD PIO 20/15 combines two antidiabetic medications, Teneligliptin and Pioglitazone, in a single formulation. This combination is designed to manage type 2 diabetes mellitus by targeting different aspects of glucose metabolism, thereby improving glycemic control in patients who are inadequately controlled with monotherapy or require dual therapy.\n\nComposition\n\nTeneligliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and reduces glucagon release, thereby lowering blood glucose levels.\nPioglitazone: A thiazolidinedione (TZD) that improves insulin sensitivity in peripheral tissues (muscle and adipose tissue) and reduces hepatic glucose production.\nMechanism of Action\n\nTeneligliptin: Inhibits the degradation of incretin hormones (GLP-1 and GIP), which play a key role in glucose-dependent insulin secretion and suppression of glucagon secretion.\nPioglitazone: Activates peroxisome proliferator-activated receptor gamma (PPAR-γ), leading to improved insulin sensitivity, enhanced glucose uptake in peripheral tissues, and reduced hepatic glucose production.\nIndications\nTENELIGOLD PIO 20/15 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults who are inadequately controlled with diet and exercise alone or with other antidiabetic medications.\nDosage and Administration\n\nThe typical dosage is one tablet of TENELIGOLD PIO 20/15 taken orally once daily, preferably with meals.\nDosage adjustments may be necessary based on individual patient response and tolerability.\nIt is important to adhere to the prescribed dosage regimen to achieve optimal glycemic control.\nSide Effects\nCommon side effects may include:\n\nHypoglycemia (especially when used in combination with insulin or sulfonylureas)\nEdema (fluid retention)\nWeight gain\nHeadache\nNasopharyngitis (common cold)\nMore severe side effects can include:\n\nHeart failure (especially in patients with pre-existing cardiovascular disease)\nHepatic dysfunction (monitor liver function tests periodically)\nBone fractures (especially in women)\nPrecautions\n\nHeart Failure: Use with caution in patients with a history of heart failure or other cardiovascular diseases.\nBladder Cancer: Pioglitazone has been associated with an increased risk of bladder cancer; therefore, it should be used cautiously in patients with a history of bladder cancer or with risk factors.\nLiver Function: Monitor liver function tests before starting treatment and periodically thereafter, as Pioglitazone may cause hepatic dysfunction.\nPregnancy and Lactation: Use during pregnancy and lactation should be avoided unless the potential benefits outweigh the risks.\nDrug Interactions\n\nInsulin/Sulfonylureas: Increased risk of hypoglycemia when used concomitantly with insulin or sulfonylureas.\nGemfibrozil: May increase Pioglitazone levels, requiring dose adjustment.\nCYP2C8 Inhibitors (e.g., Gemfibrozil): May increase Pioglitazone concentrations, necessitating monitoring for adverse effects.\nConclusion\nTENELIGOLD PIO 20/15 offers a dual-action approach to managing type 2 diabetes mellitus by combining Teneligliptin and Pioglitazone. This combination helps improve glycemic control through different mechanisms: enhancing insulin secretion and sensitivity. It is crucial to use this medication under the guidance of a healthcare professional to optimize treatment outcomes while minimizing the risk of side effects. Regular monitoring for efficacy and safety parameters, including blood glucose levels and potential adverse effects, is essential for managing diabetes effectively with TENELIGOLD PIO 20/15.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "key role", "one tablet", "Weight gain", "common cold", "risk factors", "dual therapy", "Heart failure", "increased risk", "dosage regimen", "typical dosage", "Bladder Cancer", "Bone fractures", "adipose tissue", "TENELIGOLD PIO", "glucose uptake", "dose adjustment", "fluid retention", "glucagon release", "DPP-4) inhibitor", "safety parameters", "CYP2C8 Inhibitors", "Drug Interactions", "incretin hormones", "different aspects", "Regular monitoring", "treatment outcomes", "Dosage adjustments", "peripheral tissues", "single formulation", "glucagon secretion", "potential benefits", "glucose metabolism", "insulin sensitivity", "Pioglitazone levels", "Hepatic dysfunction", "Common side effects", "different mechanisms", "dual-action approach", "liver function tests", "blood glucose levels", "dipeptidyl peptidase-4", "healthcare professional", "optimal glycemic control", "type 2 diabetes mellitus", "More severe side effects", "potential adverse effects", "hepatic glucose production", "Pioglitazone concentrations", "individual patient response", "two antidiabetic medications", "other cardiovascular diseases", "other antidiabetic medications", "existing cardiovascular disease", "glucose-dependent insulin secretion", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1935, "imageuri": "https://productimages.withfloats.com/actual/668e77ebf07c99c3af8e6d67.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e77ebf07c99c3af8e6d67.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T12:00:40.528Z", "updatedon": "2024-07-10T12:00:40.528Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//teneligold-pio-20-15-/1935", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PIO 20/15 ", "category": "DIABETIC RANGE", "tags": [ "teneligliptin + pioglitazone brand name", "Zita Plus Pio", "Teneligliptin + Pioglitazone Metformin", "Zita Piomet 1000", "Teneligliptin 20 MG and Pioglitazone 15 MG tablets", "Dapagliflozin", "Zita Piomet 500" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }